Indaptus Therapeutics, Inc.

Indaptus Therapeutics is a biotechnology company dedicated to developing novel therapies for cancer and infectious diseases. They leverage a unique platform that harnesses the body's natural immune response to fight disease. The company's approach focuses on creating attenuated and killed non-pathogenic gram-negative bacteria that safely activate both innate and adaptive immune pathways. This unique approach has demonstrated broad anti-tumor and anti-viral activity in pre-clinical models, including the ability to eradicate established tumors in combination with other therapies.

Indaptus Therapeutics is headquartered in New York City and has initiated their first Phase 1 clinical trial for their lead candidate, Decoy20. They have assembled a team of experts driven to develop cures for patients and are committed to building a corporate culture that values inclusivity, intellectual honesty, and open communication. Their mission is to revolutionize the treatment of cancer and infectious diseases by harnessing the body's own immune system, making their technology a potential game-changer in the fight against these devastating conditions.

Indaptus Therapeutics is a biotechnology company dedicated to revolutionizing the treatment of cancer and certain infectious diseases by harnessing the power of the immune system. Their unique approach utilizes engineered, non-pathogenic bacteria to activate both the innate and adaptive immune responses, offering a potentially safe and effective way to cure disease. They are currently advancing a pipeline of proprietary bacterial candidates, including their lead candidate Decoy20, which has demonstrated broad anti-tumor and anti-viral activity in pre-clinical models.

Indaptus Therapeutics cultivates a culture that values inclusivity, intellectual honesty, and open communication. They emphasize a collaborative environment where experts work together to achieve their shared goal of developing cures for patients. Their commitment to "doing well by doing good" permeates their operations, encouraging employees to be driven by purpose and contribute to a meaningful cause.

Indaptus Therapeutics is committed to building a corporate culture that values inclusivity, intellectual honesty, and open communication. They believe that by fostering a diverse and inclusive environment, they can attract and retain the best talent, while also creating a workplace where everyone feels valued and respected.